Overview

Treatment of Hypertension

Status:
Completed

Trial end date:
1979-01-01

Target enrollment:

Participant gender:

Summary

To determine whether the long-term treatment of essential hypertension without significant target organ disease materially influenced mortality and/or cardiovascular renal morbidity.

Phase:

Phase 3

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Chlorothiazide